Bluejay Diagnostics Inc Cash Flow-to-Debt Ratio
Bluejay Diagnostics Inc cash flow-to-debt ratio. Bluejay Diagnostics Inc (BJDX) has a Cash Flow-to-Debt Ratio of -1.12x as of March 2026, meaning its operating cash flow of $-1.59 Million could theoretically repay -1% of its total liabilities ($1.42 Million) in one year. See Bluejay Diagnostics Inc leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Bluejay Diagnostics Inc (2019–2025)
Cash flow-to-debt ratio of Bluejay Diagnostics Inc from 2019 to 2025. Historical debt coverage capacity for Bluejay Diagnostics Inc across 7 annual periods. Also explore net asset momentum of Bluejay Diagnostics Inc to track the company's year-over-year net asset growth rate.
Bluejay Diagnostics Inc Cash Flow-to-Debt Ratio by Year (2019–2025)
Bluejay Diagnostics Inc cash flow-to-debt ratio by year from 2019 to 2025. Year-by-year debt coverage analysis for Bluejay Diagnostics Inc. For the full cash flow conversion analysis, see how efficiently does Bluejay Diagnostics Inc generate cash.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -5.29x | $-6.05 Million | $1.14 Million | ▲ +37.2% |
| 2024 | -8.43x | $-7.82 Million | $927.92K | ▼ -100.1% |
| 2023 | -4.21x | $-8.31 Million | $1.97 Million | ▼ -7.7% |
| 2022 | -3.91x | $-7.74 Million | $1.98 Million | ▲ +42.9% |
| 2021 | -6.85x | $-4.37 Million | $637.16K | ▼ -7610.8% |
| 2020 | -0.09x | $-508.71K | $5.72 Million | ▲ +79.8% |
| 2019 | -0.44x | $-1.69 Million | $3.85 Million | — |